KB
ZBH icon

Kimelman & Baird’s Zimmer Biomet ZBH Stock Holding History

Kimelman & Baird’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.7K Hold
600
– – ﹤0.01% 173
2026
Q1 		$54.3K Hold
600
– – ﹤0.01% 166
2025
Q4 		$54K Hold
600
– – ﹤0.01% 166
2025
Q3 		$59.1K Hold
600
– – ﹤0.01% 171
2025
Q2 		$54.7K Hold
600
– – ﹤0.01% 181
2025
Q1 		$67.9K Hold
600
– – 0.01% 167
2024
Q4 		$63.4K Hold
600
– – 0.01% 172
2024
Q3 		$64.8K Hold
600
– – 0.01% 173
2024
Q2 		$65.1K Buy
+600
New +$70.7K 0.01% 171
2021
Q2 		$418K Buy
+2,678
New +$434K 0.04% 87
2019
Q3 		$357K Hold
2,678
– – 0.05% 80
2019
Q2 		$306K Hold
2,678
– – 0.04% 87
2019
Q1 		$332K Hold
2,678
– – 0.05% 85
2018
Q4 		$270K Hold
2,678
– – 0.04% 88
2018
Q3 		$342K Hold
2,678
– – 0.04% 82
2018
Q2 		$290K Buy
+2,678
New +$291K 0.04% 92
2017
Q4 		$314K Hold
2,678
– – 0.04% 92
2017
Q3 		$304K Hold
2,678
– – 0.05% 96
2017
Q2 		$334K Hold
2,678
– – 0.05% 97
2017
Q1 		$317K Hold
2,678
– – 0.05% 96
2016
Q4 		$268K Hold
2,678
– – 0.04% 97
2016
Q3 		$338K Hold
2,678
– – 0.06% 79
2016
Q2 		$313K Hold
2,678
– – 0.06% 81
2016
Q1 		$277K Sell
2,678
-94
-3% -$9.09K 0.05% 92
2015
Q4 		$276K Buy
+2,772
New +$271K 0.05% 90
2015
Q2 		$294K Hold
2,772
– – 0.05% 97
2015
Q1 		$316K Hold
2,772
– – 0.06% 93
2014
Q4 		$305K Hold
2,772
– – 0.06% 97
2014
Q3 		$271K Hold
2,772
– – 0.05% 98
2014
Q2 		$279K Hold
2,772
– – 0.05% 99
2014
Q1 		$255K Buy
2,772
+94
+4% +$8.66K 0.05% 94
2013
Q4 		$242K Buy
+2,678
New +$232K 0.05% 92

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kimelman & Baird's ZBH Position: Q2 2026 in Review

Kimelman & Baird held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 600 shares worth $51.7K. The position accounts for ﹤0.01% of the portfolio, ranked #173.

Kimelman & Baird first reported a position in ZBH in Q4 2013 and has held it in 32 quarters since. The position peaked at $418K in Q2 2021. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Kimelman & Baird held 600 shares of Zimmer Biomet worth $51.7K as of Q2 2026.
  • Kimelman & Baird left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Kimelman & Baird's portfolio in Q2 2026, its #173 holding.
  • Kimelman & Baird first reported a position in Zimmer Biomet in Q4 2013 and has held it in 32 quarters since.
  • Kimelman & Baird's Zimmer Biomet position peaked at $418K in Q2 2021.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Kimelman & Baird's 13F filing for Q2 2026, filed 5 Aug 2026.